Mohan Zhao
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Venetoclax for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: Prospects, resistance mechanisms and management strategies.
Journal: Clinical and translational medicine
Published: May 30, 2026
TA-TMA occurring after sequential CD7 CAR-T cell therapy and allogeneic hematopoietic stem cell transplantation: a case report.
Journal: Frontiers in immunology
Published: March 16, 2026
Identification and validation of lymphangiogenesis-related genes for predicting acute myeloid leukemia prognosis: insights from bulk RNA sequencing and single-cell RNA sequencing analyses.
Journal: Clinical and experimental medicine
Published: November 01, 2025
SLC43A2-mediated immune cell infiltration: a potential therapeutic target in acute myeloid leukemia.
SLC43A2-mediated immune cell infiltration: a potential therapeutic target in acute myeloid leukemia.
Journal: Frontiers in immunology
Published: June 28, 2025
A novel fourth generation of CAR-T cells: CD19 CAR-T cells engineered to express membrane-bound interleukin-15 and CXCR5 for the treatment of lymphoma.
Journal: Clinical and experimental medicine
Published: June 12, 2025
A novel malnutrition assessment model predicts the inflammatory storm of relapsed/refractory acute myeloid leukemia following C-type lectin-like molecule-1 chimeric antigen receptor T therapy.
Journal: Frontiers in nutrition
Published: May 13, 2025
Split CAR-T cells targeting CD312 and TIM-3 for acute myeloid leukemia to reduce the risk of antigen escape.
Journal: Chinese medical journal
Published: April 14, 2025
A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis.
Journal: Frontiers in oncology
Published: December 22, 2024
Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia.
Journal: Translational oncology
Published: August 01, 2024
Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia.
Journal: Journal of translational medicine
Published: June 25, 2024
Case report: Successful combination of CLL1 CAR-T therapy and hematopoietic stem cell transplantation in a 73-year-old patient diagnosed with refractory acute myeloid leukemia.
Journal: Frontiers in immunology
Published: June 25, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026